|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-4-20
|
|
pubmed:abstractText |
To determine the epidemiology of myeloid leukaemia (ML) in children with Down syndrome (DS) and the efficacy of two approaches, low-dose cytarabine-based regimen (LDC) and standard-dose intensive chemotherapy (SD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
927-33
|
|
pubmed:meshHeading |
pubmed-meshheading:20405513-Antineoplastic Agents,
pubmed-meshheading:20405513-Child, Preschool,
pubmed-meshheading:20405513-Cytarabine,
pubmed-meshheading:20405513-Disease-Free Survival,
pubmed-meshheading:20405513-Dose-Response Relationship, Drug,
pubmed-meshheading:20405513-Down Syndrome,
pubmed-meshheading:20405513-Female,
pubmed-meshheading:20405513-France,
pubmed-meshheading:20405513-Humans,
pubmed-meshheading:20405513-Infant,
pubmed-meshheading:20405513-Leukemia, Myeloid,
pubmed-meshheading:20405513-Male,
pubmed-meshheading:20405513-Registries,
pubmed-meshheading:20405513-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.
|
|
pubmed:affiliation |
Bordeaux University and Bordeaux University Hospital, Pediatric Oncology and Hematology Unit, 33076 Bordeaux, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
